Chronic Myeloid Leukemia
A brief digest about this topic
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, however, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In chronic myeloid leukemia (CML), there are too many of a specific type of white blood cell called a granulocyte.
Sometimes CML does not cause any symptoms at all. If you have symptoms, they may include:
- Feeling very tired
- Weight loss
- Night sweats
- Fever
- Pain or a feeling of fullness below the ribs on the left side
Tests that examine the blood and bone marrow diagnose CML. Treatments include chemotherapy, radiation therapy, stem cell transplants, infusion of donated white blood cells following stem cell transplants, immune therapy, or surgery to remove the spleen.
NIH: National Cancer Institute
Provided by: NIH - National Institute of Health
Links shared publicly online about this topic
Chronic Myeloid Leukemia: New Approaches Needed
medicalnewstoday.com — “Chronic myeloid leukemia (CML) was transformed from a fatal disease to a chronic condition by the development of a drug known as imatinib, which targets the protein that drives this disease (BCR-A” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 1:05 pm By:
Chronic Myeloid Leukemia: New Approaches Needed http://mnt.to/3P3M #lymphoma #leukemia
Medicine and Technology [part of HCPLive]: Optimal treatment for CML (Chronic Myeloid Leukemia)
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: Optimal treatment for CML (Chronic Myeloid Leukemia)” View full resource at medicineandtechnology.com
Most Recently Shared on June 7, 2010 at 1:50 pm By:
Joseph Kim, MD, MPH Doctor and Physician
Optimal treatment for CML (Chronic Myeloid Leukemia) http://bit.ly/bM5HtV
Chronic Myeloid Leukemia: New Lab Test Could Identify Imatinib Resistance
medicalnewstoday.com — “Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid leukemia (CML).” View full resource at medicalnewstoday.com
Most Recently Shared on July 29, 2010 at 3:07 pm By:
Chronic Myeloid Leukemia: New Lab Test Could Identify Imatinib Resistance http://mnt.to/3GJC #lymphoma #leukemia
NICE Recommends Nilotinib for Chronic Myeloid Leukemia - OncologySTAT
oncologystat.com — “NICE Recommends Nilotinib for Chronic Myeloid Leukemia - Elsevier Global Medical News. 2011 Aug 17, J Smith” View full resource at oncologystat.com
Most Recently Shared on August 23, 2011 at 9:56 pm By:
Price cut makes NICE withdraw their negative 'cost effectiveness' appraisal of Nilotinib in 2nd line CML treatment in UK http://ow.ly/6aXXN
Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects
jnci.oxfordjournals.org — “Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects” View full resource at jnci.oxfordjournals.org
Most Recently Shared on March 24, 2011 at 9:40 am By:
Oxford Journals(OUP) Medical Journal
Also, accompanying editorial for @JNCI_Now paper http://bit.ly/f4yqKm #leukemia #cancer #drugs #mortality
Chronic Myeloid Leukemia: Second-Line Drug Evokes Faster Response, Fewer Side Effects, Pivotal Study Finds
medicalnewstoday.com — “Dasatanib, a medication currently approved as treatment for drug-resistant chronic myeloid leukemia (CML), provided patients with quicker, better responses as a first therapy than the existing fro” View full resource at medicalnewstoday.com
Most Recently Shared on June 7, 2010 at 12:06 pm By:
Chronic Myeloid Leukemia: Second-Line Drug Evokes Faster Response, Fewer Side Effects, Pivotal Study Finds http://mnt.to/3Dz6
Faces of Chronic Myeloid Leukemia: Perspectives from all across the world - CML Advocates Network
cmladvocates.net — “Global network of patient groups supporting patients with Chronic Myeloid Leukemia (CML), connecting more than 50 groups in more than 40 countries on all continents” View full resource at cmladvocates.net
Most Recently Shared on September 12, 2011 at 3:52 pm By:
CML has different faces! See the 98 photos here - more coming in day by day! http://ow.ly/6s0u8
Oncology Article | Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response
mdlinx.com — “Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response” View full resource at mdlinx.com
Most Recently Shared on October 14, 2011 at 7:42 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Ph... http://t.co/QcxBed17 #oncology
Chronic myeloid leukemia: New lab test could identify imatinib resistance Scientists in Japan may have developed a way .. http://dld.bz/rJBG
sciencedaily.com — “Chronic myeloid leukemia: New lab test could identify imatinib resistance Scientists in Japan may have developed a way .. http://dld.bz/rJBG” View full resource at sciencedaily.com
Most Recently Shared on August 13, 2010 at 4:07 pm By:
Chronic myeloid leukemia: New lab test could identify imatinib resistance Scientists in Japan may have developed a way .. http://dld.bz/rJBG
Chronic myeloid leukemia: New lab test could identify imatinib resistance: Scientists in Japan may have developed ... http://bit.ly/c3YmnM
sciencedaily.com — “Chronic myeloid leukemia: New lab test could identify imatinib resistance: Scientists in Japan may have developed ... http://bit.ly/c3YmnM” View full resource at sciencedaily.com
Most Recently Shared on July 29, 2010 at 2:21 pm By:
Chronic myeloid leukemia: New lab test could identify imatinib resistance: Scientists in Japan may have developed ... http://bit.ly/c3YmnM
Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase Stem Cells on #MDlinx
mdlinx.com — “Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase Stem Cells on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 8, 2010 at 6:49 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 rece... http://bit.ly/bj5XvL #oncology
Oncology Article | Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase
mdlinx.com — “Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase following imatinib resistance or intolerance: 24-month follow-up results” View full resource at mdlinx.com
Most Recently Shared on November 29, 2010 at 5:01 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase following imatinib r... http://bit.ly/ewAMpa #oncology
Oncology Article | Leukemia, Myeloid, Chronic-Phase
mdlinx.com — “First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib” View full resource at mdlinx.com
Most Recently Shared on December 17, 2010 at 9:08 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib: Journal of Hemat... http://bit.ly/dJLhIn #oncology
Oncology Article | Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase
mdlinx.com — “Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia” View full resource at mdlinx.com
Most Recently Shared on May 9, 2011 at 6:38 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentrat... http://bit.ly/iC5ZSy #oncology
Oncology Article | Leukemia, Myeloid
mdlinx.com — “Imatinib Sensitivity in BCR-ABL1–Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele” View full resource at mdlinx.com
Most Recently Shared on August 29, 2011 at 3:58 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Imatinib Sensitivity in BCR-ABL1–Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining... http://t.co/57s3aPy #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Leukemia
The latest lymphoma and leukemia news published daily. Articles from research centers, universities and prestigious journals.
-
Joseph Kim, MD, MPH
Physician, MIT engineer, technology advocate, blogger: MedicineandTechnology.com NonClinicalJobs.com MedicalSmartphones.com MobileHealthComputing.com
-
MNT Leukemia
The latest lymphoma and leukemia news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
